Danish Medical Journal, published by the esteemed Danish Medical Association, is a vital platform in the field of medicine, providing open access research that reflects the current advances and innovations within the medical community. With an E-ISSN of 2245-1919, this journal has established itself as a significant contributor to the discourse in general medicine, holding a commendable Q3 rank in Scopus for 2023 and placed in the 65th percentile among its peers. The journal aims to disseminate high-quality research from Denmark and beyond, fostering collaboration and dialogue across disciplines. Researchers, healthcare professionals, and students alike will find invaluable insights into contemporary medical issues and evidence-based practices within its pages. The journal, which has successfully converged its focus from 2012 to 2024, is committed to continuing its legacy of excellence and innovation in medical literature, ensuring that readers remain at the forefront of medical science.

European Journal of Therapeutics is a distinguished journal dedicated to advancing the field of therapeutic sciences through high-quality research and innovative clinical practice. Published by Pera Yayincilik Hizmetleri, this interdisciplinary journal aims to facilitate knowledge dissemination in areas such as pharmacology, clinical medicine, and public health, thereby supporting both researchers and practitioners in improving therapeutic outcomes. Although the journal operates under a subscription model, its commitment to rigorous peer review ensures that published articles reflect the latest advancements and methodologies. With a growing emphasis on evidence-based therapies, the European Journal of Therapeutics serves as a vital platform for dialogue among healthcare professionals and researchers, enhancing the understanding of therapeutic interventions on a global scale. It welcomes contributions ranging from original research to review articles, making it an essential resource for those seeking to enrich their knowledge and influence practice in therapeutic approaches.

HEALTH TECHNOLOGY ASSESSMENT is a prestigious open-access journal published by the NIHR Journals Library, focusing on advancing the science of health technology assessment through robust research and critical analysis in the fields of Health Policy and Medicine. Since its inception in 2001, this journal has fostered a multidisciplinary approach to evaluating health technologies, offering invaluable insights to researchers, healthcare professionals, and policymakers. With an impressive Q1 ranking in both Health Policy and Medicine (miscellaneous) for 2023, it stands at the forefront of academic discourse, reflecting a high-impact factor and an esteemed reputation within its respective categories. The journal not only publishes original research articles, but also reviews and case studies that illuminate the complexities of health technology in real-world applications. Established and based in the United Kingdom, HEALTH TECHNOLOGY ASSESSMENT strives to encourage evidence-based decision-making, making it an essential resource for anyone committed to enhancing healthcare outcomes through innovative technology assessments.

Psoriasis-Targets and Therapy is a leading open-access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the knowledge and understanding of psoriasis treatment and management. Launched in 2011, this journal provides a platform for high-quality research that encompasses clinical studies, therapeutic advances, and novel targeted therapies for psoriasis. With a focus on the latest findings and innovative approaches, Psoriasis-Targets and Therapy serves as an essential resource for researchers, healthcare professionals, and students seeking to stay at the forefront of this dynamic field. The journal's commitment to open-access publishing ensures that critical insights and breakthroughs are readily available to the global medical community, fostering collaboration and progress in psoriasis treatment strategies. Researchers are encouraged to submit their findings to contribute to the growing body of knowledge that will ultimately improve patient care and outcomes.

Journal of Pioneering Medical Sciences, published by JPMS PUBL in Karachi, Pakistan, stands as a vital resource in the field of medical research and practice. Established in 2012, this Open Access journal fosters the dissemination of innovative findings and groundbreaking studies that contribute to the advancement of medical science. With an ISSN of 2309-7981 and a commitment to rigorous peer-review, the journal encompasses a diverse range of topics, aiming to bridge knowledge gaps and promote interdisciplinary dialogue among healthcare professionals and researchers. Although it currently lacks an H-index, its focus on pioneering medical studies positions it as a platform for impactful contributions that can shape future healthcare policies and practices. The journal's open access policy ensures that vital research is freely available to a global audience, promoting accessibility and collaboration in the medical community.

ANNALS ACADEMY OF MEDICINE SINGAPORE is a reputable journal dedicated to the field of medicine, published by the Academy of Medicine, Singapore. With an E-ISSN of 2972-4066, this journal has been an influential platform since its inception in 1973, aiming to disseminate high-quality research and clinical findings pertinent to both local and international audiences. Currently ranked in the Q3 quartile in Medicine (miscellaneous), it holds a commendable 83rd percentile in Scopus rankings, indicating its significant academic contribution within the competitive landscape of medical literature. Although the journal operates on a traditional subscription-based model, it continues to provide access to critical insights that serve not only researchers but also healthcare professionals and students engaged in the ever-evolving medical sector. As it approaches its comprehensive publication mark in 2024, ANNALS will continue to focus on enhancing global healthcare discourse, making it an invaluable resource for those committed to advancing medical knowledge and practice.

Clinical Therapeutics, published by Elsevier, is a highly esteemed peer-reviewed journal that has been pivotal in advancing the field of pharmacology since its inception in 1977. With an impressive impact factor and recognition as Q2 in Pharmacology and Q1 in Medical Pharmacology for 2023, it stands at the forefront of research and discussions on innovative therapeutic strategies and pharmacological advancements. This journal not only caters to a broad audience of researchers and clinicians but also plays a vital role in disseminating critical information that supports the enhancement of patient care and safety. As a repository of high-quality, evidence-based articles, Clinical Therapeutics is a crucial resource for those involved in drug development, medical research, and clinical practice, making it an essential read for anyone dedicated to improving health outcomes through pharmaceutical sciences.

WIENER MEDIZINISCHE WOCHENSCHRIFT, published by SPRINGER WIEN, stands as a pivotal journal in the field of general medicine, with a significant history dating back to its inception in 1946. With its ISSN 0043-5341 and E-ISSN 1563-258X, this journal seeks to bridge the gap between research and clinical practice, offering a platform for the dissemination of vital medical knowledge and innovations. While currently placed in the Q3 quartile of the medicine category and ranking #210 out of 636 in Scopus, it boasts a 67th percentile ranking, underscoring its impact and relevance among practitioners and researchers alike. Although not an open-access journal, its accessibility through institutional subscriptions ensures that a wide audience can engage with its comprehensive articles that cover myriad topics in medicine. As the field continuously evolves, WIENER MEDIZINISCHE WOCHENSCHRIFT is committed to advancing medical understanding and fostering discussions that resonate within Austria and beyond, making it an essential resource for healthcare professionals, academia, and students seeking to stay abreast of current medical advancements.

Mayo Clinic Proceedings is a premier peer-reviewed medical journal published by Elsevier Science Inc, dedicated to advancing clinical practice through high-quality research, reviews, and case reports since its inception in 1945. With an impressive impact factor and recognized as a Q1 journal in the Medicine (miscellaneous) category, it ranks as #21 out of 636 in the realm of General Medicine, placing it in the top 96th percentile among its peers. The journal serves as a vital resource for healthcare professionals, researchers, and students by promoting evidence-based medicine that addresses contemporary challenges in clinical practice. Although it does not currently offer open access options, its rigorous publication standards ensure that its findings are credible and relevant, making it an essential platform for disseminating significant medical advancements. With a commitment to progress in healthcare, the Mayo Clinic Proceedings continues to shape the future of medicine for audiences across the globe.

ADVANCES IN THERAPY is a prestigious peer-reviewed journal published by SPRINGER, specializing in the diverse fields of medicine and pharmacology. Established in 1984, this influential journal has become an essential resource for researchers and professionals, boasting a commendable impact factor and categorically ranking within the Q1 quartile in both Medicine (Miscellaneous) and Medical Pharmacology as of 2023. With an impressive Scopus ranking at #52 out of 272 in the realm of medical pharmacology, it places itself in the top 81st percentile, underscoring its importance in advancing therapeutic knowledge and practices. Although the journal is not open access, it provides invaluable insights and the latest research findings in therapies that significantly impact patient care, making it a vital reference for clinicians, academicians, and students alike.